Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanan Ren

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Oncogenesis|July 12, 2025
Ketone drink enhances therapeutic efficacy in prostate cancer by targeting EZH2Chaehyun Yum, Richard A Schaefer, Rui Wang, et al.
Journal of Child and Adolescent Psychopharmacology|July 14, 2018
Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label StudyKathryn R Cullen, Palistha Amatya, Mark G Roback, et al.
Science Advances|April 9, 2025
Androgen receptor-regulated lncRNA PRCAT71 promotes AR signaling through the interaction with KHSRP in prostate cancerYongyong Yang, Ting-You Wang, Qianru Li, et al.
Scientific Reports|July 11, 2020
Inhalation exposure to cigarette smoke and inflammatory agents induces epigenetic changes in the lungChristopher L Seiler, J Ung Min Song, Delshanee Kotandeniya, et al.
Cell Death & Disease|November 7, 2025
The RNA N<sup>6</sup>-methyladenosine methylome coordinates long non-coding RNAs to mediate cancer drug resistance by activating PI3K signalingYanhong Tan, Changli Zhou, Sicheng Bian, et al.
Science Advances|November 27, 2024
EZH2 directly methylates PARP1 and regulates its activity in cancerQingshu Meng, Jiangchuan Shen, Yanan Ren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Nature Communications|March 20, 2026
Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signalingYongyong Yang, Ting-You Wang, Joshua Fry, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Oncogenesis|July 12, 2025
Ketone drink enhances therapeutic efficacy in prostate cancer by targeting EZH2Chaehyun Yum, Richard A Schaefer, Rui Wang, et al.
Journal of Child and Adolescent Psychopharmacology|July 14, 2018
Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label StudyKathryn R Cullen, Palistha Amatya, Mark G Roback, et al.
Science Advances|April 9, 2025
Androgen receptor-regulated lncRNA PRCAT71 promotes AR signaling through the interaction with KHSRP in prostate cancerYongyong Yang, Ting-You Wang, Qianru Li, et al.
Scientific Reports|July 11, 2020
Inhalation exposure to cigarette smoke and inflammatory agents induces epigenetic changes in the lungChristopher L Seiler, J Ung Min Song, Delshanee Kotandeniya, et al.
Cell Death & Disease|November 7, 2025
The RNA N<sup>6</sup>-methyladenosine methylome coordinates long non-coding RNAs to mediate cancer drug resistance by activating PI3K signalingYanhong Tan, Changli Zhou, Sicheng Bian, et al.
Science Advances|November 27, 2024
EZH2 directly methylates PARP1 and regulates its activity in cancerQingshu Meng, Jiangchuan Shen, Yanan Ren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Nature Communications|March 20, 2026
Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signalingYongyong Yang, Ting-You Wang, Joshua Fry, et al.
Pageof 11